Thyrotropin-releasing hormone in rat heart: effect of swelling, angiotensin II and renin gene

$48.00 plus tax (Refund Policy)

Download / Buy Article:

Abstract:

Abstract Aim: 

This study was performed to examine thyrotropin-releasing hormone (TRH) secretion and regulation in rat heart. Methods: 

Expression of prepro-TRH gene in left atrium and left ventricle was studied by RT-PCR. TRH secretion from slices of left auricle and left ventricle in response to cell swelling (induced by hypotonic medium or ethanol in isosmotic medium), angiotensin II and losartan and their combinations was studied. Results: 

RT-PCR revealed two times higher prepro-TRH expression in left auricle than left ventricle. In transgenic rats with extra copy of mouse renin gene a marked increase of prepro-TRH expression in the heart was noted but the relative difference between left atrium and left ventricle persisted. The swelling stimulated TRH release from both left auricle and left ventricle and this stimulation could not be inhibited by bumetanide. Angiotensin II (10 nmol L−1) added into medium significantly decreased basal secretion of TRH. The inhibiting effect of Angiotensin II was prevented by 1 mol L−1 losartan, an angiotensin II AT1 receptor blocker. When angiotensin II and hypotonicity were applied simultaneously, swelling-induced secretion persisted. Conclusion: 

TRH secretion from heart slices has attributes of regulated secretion – depending on the stimulus it could be either stimulated or inhibited. Renin positively affects prepro-TRH expression in the heart. Angiotensin II inhibits TRH secretion from heart tissue by a mechanism involving AT1 receptors. Swelling-induced TRH secretion overrides inhibitory effect of angiotensin II. Swelling could be a useful tool when natural or pharmacological secretagogue is unknown. Peptides and proteins released by swelling could be mediators of local and remote ischaemic preconditioning protecting from subsequent ischaemia.

Keywords: Losartan; angiotensin II; heart; rat; renin; swelling; thyrotropin-releasing hormone; transgenic

Document Type: Research Article

DOI: http://dx.doi.org/10.1111/j.1748-1716.2006.01545.x

Affiliations: 1: Institute of Experimental Endocrinology, Slovak Academy of Sciences, Bratislava, Slovak Republic 2: Department of Internal Medicine, Ruzinov, Faculty of Medicine, Comenius University, Bratislava, Slovak Republic 3: Department of Animal Physiology and Ethology, Comenius University Bratislava, Slovak Republic

Publication date: May 1, 2006

Related content

Tools

Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more